CDC Morbidity & Mortality Weekly Report: Clinical Recommendation for the Use of Injectable Lenacapavir as HIV Preexposure Prophylaxis -- United States, 2025
September 21, 2025
September 21, 2025
ATLANTA, Georgia, Sept. 21 (TNSLrpt) -- The U.S. Department of Health and Human Services Centers for Disease Control and Prevention issued the following document as part of its Morbidity and Mortality Weekly Report (No. 35) on September 18, 2025, entitled "Clinical Recommendation for the Use of Injectable Lenacapavir as HIV Preexposure Prophylaxis -- United States, 2025.":
Here are excerpts:
* * *
Summary
What is already known about t . . .
Here are excerpts:
* * *
Summary
What is already known about t . . .